266 related articles for article (PubMed ID: 26248647)
1. The new biology of diabetes.
Pajvani UB; Accili D
Diabetologia; 2015 Nov; 58(11):2459-68. PubMed ID: 26248647
[TBL] [Abstract][Full Text] [Related]
2. Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.
Haeusler RA; Hartil K; Vaitheesvaran B; Arrieta-Cruz I; Knight CM; Cook JR; Kammoun HL; Febbraio MA; Gutierrez-Juarez R; Kurland IJ; Accili D
Nat Commun; 2014 Oct; 5():5190. PubMed ID: 25307742
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of FOXO transcription factors in pancreatic beta cells.
Glauser DA; Schlegel W
J Endocrinol; 2007 May; 193(2):195-207. PubMed ID: 17470511
[TBL] [Abstract][Full Text] [Related]
4. Forkhead box class O family member proteins: The biology and pathophysiological roles in diabetes.
Tsuchiya K; Ogawa Y
J Diabetes Investig; 2017 Nov; 8(6):726-734. PubMed ID: 28267275
[TBL] [Abstract][Full Text] [Related]
5. Silencing of forkhead box protein O-1 (FOXO-1) enhances insulin-producing cell generation from adipose mesenchymal stem cells for diabetes therapy.
Kamal MM; Ammar RA; Kassem DH
Life Sci; 2024 May; 344():122579. PubMed ID: 38518842
[TBL] [Abstract][Full Text] [Related]
6. Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice.
Kim-Muller JY; Zhao S; Srivastava S; Mugabo Y; Noh HL; Kim YR; Madiraju SR; Ferrante AW; Skolnik EY; Prentki M; Accili D
Cell Metab; 2014 Oct; 20(4):593-602. PubMed ID: 25264246
[TBL] [Abstract][Full Text] [Related]
7. The Role of Forkhead Box O in Pathogenesis and Therapy of Diabetes Mellitus.
Marchelek-Mysliwiec M; Nalewajska M; Turoń-Skrzypińska A; Kotrych K; Dziedziejko V; Sulikowski T; Pawlik A
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232910
[TBL] [Abstract][Full Text] [Related]
8. Nephrin, a transmembrane protein, is involved in pancreatic beta-cell survival signaling.
Kapodistria K; Tsilibary EP; Politis P; Moustardas P; Charonis A; Kitsiou P
Mol Cell Endocrinol; 2015 Jan; 400():112-28. PubMed ID: 25448064
[TBL] [Abstract][Full Text] [Related]
9. [New aspects of pancreatic beta cell functions and their possible therapeutic applications].
Tiedge M
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S226-30. PubMed ID: 17139575
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Hepatic Glucose Metabolism by FoxO Proteins, an Integrated Approach.
Unterman TG
Curr Top Dev Biol; 2018; 127():119-147. PubMed ID: 29433735
[TBL] [Abstract][Full Text] [Related]
11. When β-cells fail: lessons from dedifferentiation.
Accili D; Talchai SC; Kim-Muller JY; Cinti F; Ishida E; Ordelheide AM; Kuo T; Fan J; Son J
Diabetes Obes Metab; 2016 Sep; 18 Suppl 1(Suppl 1):117-22. PubMed ID: 27615140
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.
Talchai C; Xuan S; Lin HV; Sussel L; Accili D
Cell; 2012 Sep; 150(6):1223-34. PubMed ID: 22980982
[TBL] [Abstract][Full Text] [Related]
13. Metabolic signaling of insulin secretion by pancreatic β-cell and its derangement in type 2 diabetes.
Zou CY; Gong Y; Liang J
Eur Rev Med Pharmacol Sci; 2014; 18(15):2215-27. PubMed ID: 25070829
[TBL] [Abstract][Full Text] [Related]
14. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
Matsumoto M; Pocai A; Rossetti L; Depinho RA; Accili D
Cell Metab; 2007 Sep; 6(3):208-16. PubMed ID: 17767907
[TBL] [Abstract][Full Text] [Related]
15. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
[TBL] [Abstract][Full Text] [Related]
16. Reversing pancreatic β-cell dedifferentiation in the treatment of type 2 diabetes.
Son J; Accili D
Exp Mol Med; 2023 Aug; 55(8):1652-1658. PubMed ID: 37524865
[TBL] [Abstract][Full Text] [Related]
17. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of prediabetes.
Ferrannini E; Gastaldelli A; Iozzo P
Med Clin North Am; 2011 Mar; 95(2):327-39, vii-viii. PubMed ID: 21281836
[TBL] [Abstract][Full Text] [Related]
19. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1.
Nakae J; Biggs WH; Kitamura T; Cavenee WK; Wright CV; Arden KC; Accili D
Nat Genet; 2002 Oct; 32(2):245-53. PubMed ID: 12219087
[TBL] [Abstract][Full Text] [Related]
20. Role of FoxO Proteins in Pancreatic beta Cells.
Kitamura T; Ido Kitamura Y
Endocr J; 2007 Aug; 54(4):507-15. PubMed ID: 17510498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
